Literature DB >> 22584119

Perifosine sensitizes UVB-induced apoptosis in skin cells: new implication of skin cancer prevention?

Chao Ji1, Yan-li Yang, Zhi Yang, Ying Tu, Lei Cheng, Bin Chen, Ji-ping Xia, Wei-ling Sun, Zhong-lan Su, Li He, Zhi-gang Bi.   

Abstract

We demonstrate here that a relative low dose of perifosine significantly enhanced UVB-induced apoptosis in skin cells (keratinocytes and fibroblasts), associated with a significant increase of reactive oxygen species (ROS) and ceramide production as well as multiple perturbations of diverse cell signaling pathways, shifting to a significant pro-apoptosis outcomes. Perifosine inhibited UVB-induced pro-survival Akt/mammalian target of rapamycin (mTOR) and ERK activation, while facilitating pro-apoptotic AMP-activated protein kinas (AMPK), c-Jun-NH(2)-kinase (JNK), and p53 activation; these signaling changes together promoted a striking increase in skin cell apoptosis and a significantly reduced amount of DNA damages. Our results suggest that perifosine may represent a novel skin cancer prevention strategy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584119     DOI: 10.1016/j.cellsig.2012.05.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  22 in total

1.  Protective effect of Schizandrin B against damage of UVB irradiated skin cells depend on inhibition of inflammatory pathways.

Authors:  Chenguang Gao; Hong Chen; Cong Niu; Jie Hu; Bo Cao
Journal:  Bioengineered       Date:  2016-09-30       Impact factor: 3.269

2.  Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo.

Authors:  Jianli Zhang; Yue Hong; Jie Shen
Journal:  Tumour Biol       Date:  2015-02-20

3.  HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway.

Authors:  Weijun Liu; Zhenyong Zhang; Yongxue Zhang; Xinju Chen; Shikui Guo; Yi Lei; Yu Xu; Chao Ji; Zhigang Bi; Kunhua Wang
Journal:  Cancer Biol Ther       Date:  2015-03-16       Impact factor: 4.742

4.  TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70.

Authors:  Zhiyu Chen; Xiaolu Shen; Fengyan Shen; Wei Zhong; Hai Wu; Sha Liu; Jiang Lai
Journal:  Mol Cell Biochem       Date:  2013-02-02       Impact factor: 3.396

5.  Preclinical evaluation of perifosine as a potential promising anti-rhabdomyosarcoma agent.

Authors:  Jie Shen; Yue Hong; Qiong Zhao; Jian-Li Zhang
Journal:  Tumour Biol       Date:  2015-08-13

Review 6.  The role of AKT/mTOR pathway in stress response to UV-irradiation: implication in skin carcinogenesis by regulation of apoptosis, autophagy and senescence.

Authors:  Elwira Strozyk; Dagmar Kulms
Journal:  Int J Mol Sci       Date:  2013-07-24       Impact factor: 5.923

7.  Salinomycin activates AMP-activated protein kinase-dependent autophagy in cultured osteoblastoma cells: a negative regulator against cell apoptosis.

Authors:  Lun-qing Zhu; Yun-fang Zhen; Ya Zhang; Zhi-xiong Guo; Jin Dai; Xiao-dong Wang
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

8.  Ultraviolet (UV) and hydrogen peroxide activate ceramide-ER stress-AMPK signaling axis to promote retinal pigment epithelium (RPE) cell apoptosis.

Authors:  Jin Yao; Hui-E Bi; Yi Sheng; Li-Bo Cheng; Ri-Le Wendu; Cheng-Hu Wang; Guo-Fan Cao; Qin Jiang
Journal:  Int J Mol Sci       Date:  2013-05-17       Impact factor: 5.923

9.  Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells.

Authors:  Yan-li Yang; Chao Ji; Zhi-gang Bi; Chun-cheng Lu; Rong Wang; Bing Gu; Lei Cheng
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival.

Authors:  Ying Tu; Chao Ji; Bo Yang; Zhi Yang; Hua Gu; Chun-Cheng Lu; Rong Wang; Zhong-Lan Su; Bin Chen; Wei-Ling Sun; Ji-Ping Xia; Zhi-Gang Bi; Li He
Journal:  Mol Cancer       Date:  2013-12-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.